Skip to Content
Merck
CN

359238

Perfluorooctane

98%

Synonym(s):

Octadecafluorooctane

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Linear Formula:
CF3(CF2)6CF3
CAS Number:
Molecular Weight:
438.06
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
206-199-2
MDL number:
Assay:
98%
Form:
liquid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

YVBBRRALBYAZBM-UHFFFAOYSA-N

InChI

1S/C8F18/c9-1(10,3(13,14)5(17,18)7(21,22)23)2(11,12)4(15,16)6(19,20)8(24,25)26

SMILES string

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

assay

98%

form

liquid

refractive index

n20/D 1.3 (lit.)

bp

103-104 °C (lit.)

mp

−25 °C (lit.)

density

1.766 g/mL at 25 °C (lit.)

application(s)

PFAS testing

functional group

fluoro

Quality Level

General description

Perfluorooctane is a polyfluoroalkyl substance. Perfluorohexanoic acid (PFHxA), a 6-carbon perfluoroalkyl is an alternate of perfluorooctane. Phase behavior of semifluorinated n-alkanes in perfluorooctane has been studied .

Perfluorooctane, an oxygen carrier, is an alkane that is used as a solvent for dissolving gaseous solutes.

Application

Perfluorooctane may be used in chemical synthesis.

Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Aggregation of a semifluorinated n-alkane in perfluorooctane.
Lo Nostro P and Chen SH.
The Journal of Physical Chemistry, 97(24), 6535-6540 (1993)
Vicente Martínez-Castillo et al.
Retina (Philadelphia, Pa.), 32(7), 1350-1355 (2012-03-15)
To compare outcomes of eyes that did or did not develop an epiretinal membrane (ERM) after repair of primary pseudophakic or aphakic rhegmatogenous retinal detachment by pars plana vitrectomy alone. Interventional, prospective, consecutive case series. Of 312 consecutive eyes that
Brett Drury et al.
The British journal of ophthalmology, 95(5), 694-698 (2010-10-12)
Inferior retinal detachment pathology can be difficult to manage due to inadequate tamponade with low specific gravity tamponade agents and the propensity for the development of proliferative vitreoretinopathy (PVR). We report the efficacy and adverse effects associated with the use
Wouter A Gebbink et al.
Environmental pollution (Barking, Essex : 1987), 162, 40-47 (2012-01-17)
The comparative accumulation of C(4)-C(15) perfluorinated sulfonates (PFSAs) and carboxylates (PFCAs), and several precursors (e.g., perfluorooctane sulfonamide, N-methyl-FOSA, and fluorotelomer unsaturated acids and alcohols) was examined in tissues (liver, brain, muscle, and adipose), plasma/red blood cells (RBCs) and whole egg
Ryan Rush et al.
Retina (Philadelphia, Pa.), 32(6), 1114-1120 (2011-10-05)
To study outcomes after using perfluoro-n-octane (PFO) as a short-term postoperative vitreous substitute in eyes undergoing primary vitrectomy with or without scleral buckling for rhegmatogenous retinal detachments with inferior/multiple breaks or giant retinal tears (GRTs). Charts of 39 eyes at

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service